GLIBA // Liberty Capital Corporation Series A GCI Group
ANR <GO> NASDAQ RQD COCKPIT → CIK 0002057463 ↗| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $26.03 | $24.74 | 2025-02-14 | $19.57 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $27.10 | $25.38 | 2025-02-06 | $20.22 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $24.52 | $23.66 | 2025-01-29 | $20.65 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $21.94 | — | 2025-01-17 | $21.08 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $18.93 | $20.43 | 2025-01-09 | $19.14 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $25.60 | $22.37 | 2024-12-18 | $18.71 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $20.86 | $21.73 | 2024-12-04 | $20.00 | -4.3% | 48% | C |